Literature DB >> 33949655

SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults.

Mathilde Bellon1,2, Stephanie Baggio3,4, Frederique Jacquerioz Bausch2,5,6, Hervé Spechbach6, Julien Salamun6, Camille Genecand7, Aglae Tardin7, Laurent Kaiser2,8,9, Arnaud G L'Huillier10,9, Isabella Eckerle1,2,8,9.   

Abstract

SARS-CoV-2 viral load (VL) can serve as a correlate for infectious virus presence and transmission. Viral shedding kinetics over the first week of illness for symptomatic children (n=279), adolescents (n=639) and adults (n=7109) show VLs compatible with infectious virus presence, with slightly lower VL in children than adults.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID19; SARS-CoV2; children; viral shedding; virus transmission

Year:  2021        PMID: 33949655      PMCID: PMC8135785          DOI: 10.1093/cid/ciab396

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.

Authors:  Phimon Atsawasuwan; Dhammacari Martin Del Campo; Laura Martin Del Campo; Grace Viana; Sriram Ravindran; Veerasathpurush Allareddy; Shrihari Kadkol
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

2.  SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.

Authors:  Marc Chadeau-Hyam; Haowei Wang; Oliver Eales; David Haw; Barbara Bodinier; Matthew Whitaker; Caroline E Walters; Kylie E C Ainslie; Christina Atchison; Claudio Fronterre; Peter J Diggle; Andrew J Page; Alexander J Trotter; Deborah Ashby; Wendy Barclay; Graham Taylor; Graham Cooke; Helen Ward; Ara Darzi; Steven Riley; Christl A Donnelly; Paul Elliott
Journal:  Lancet Respir Med       Date:  2022-01-24       Impact factor: 30.700

3.  Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain.

Authors:  Carlota Dobaño; Selena Alonso; Gemma Moncunill; Iolanda Jordan; Mariona Fernández de Sevilla; Marta Vidal; Alfons Jiménez; Gemma Pons Tomas; Chenjerai Jairoce; María Melé Casas; Rocío Rubio; María Hernández García; Gemma Ruiz-Olalla; Mònica Girona-Alarcón; Diana Barrios; Rebeca Santano; Robert A Mitchell; Laura Puyol; Leonie Mayer; Jordi Chi; Natalia Rodrigo Melero; Carlo Carolis; Aleix Garcia-Miquel; Elisenda Bonet-Carne; Joana Claverol; Marta Cubells; Claudia Fortuny; Victoria Fumadó; Cristina Jou; Carmen Muñoz-Almagro; Luis Izquierdo; Quique Bassat; Eduard Gratacós; Ruth Aguilar; Juan José García-García
Journal:  BMC Med       Date:  2021-11-23       Impact factor: 8.775

4.  Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS).

Authors:  Camille Genecand; Denis Mongin; Flora Koegler; Dan Lebowitz; Simon Regard; Jean-Luc Falcone; Mayssam Nehme; Olivia Braillard; Marwène Grira; Dominique Joubert; Pierre Chopard; Elisabeth Delaporte; Jérôme Stirnemann; Idris Guessous; Aglaé Tardin; Delphine S Courvoisier
Journal:  BMJ Open       Date:  2021-11-30       Impact factor: 2.692

5.  Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.

Authors:  Marion Migueres; Chloé Dimeglio; Pauline Trémeaux; Stéphanie Raymond; Sébastien Lhomme; Isabelle Da Silva; Kévin Oliveira Mendes; Florence Abravanel; Marie-Pierre Félicé; Jean-Michel Mansuy; Jacques Izopet
Journal:  Viruses       Date:  2022-02-04       Impact factor: 5.048

6.  The SARS-CoV-2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10-19 years, middle-aged males, or elderly individuals.

Authors:  Martin Häusler; Michael Kleines
Journal:  J Med Virol       Date:  2022-03-10       Impact factor: 20.693

7.  Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study.

Authors:  Elsa Lorthe; Mathilde Bellon; Grégoire Michielin; Julie Berthelot; María-Eugenia Zaballa; Francesco Pennacchio; Meriem Bekliz; Florian Laubscher; Fatemeh Arefi; Javier Perez-Saez; Andrew S Azman; Arnaud G L'Huillier; Klara M Posfay-Barbe; Laurent Kaiser; Idris Guessous; Sebastian J Maerkl; Isabella Eckerle; Silvia Stringhini
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

8.  Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children.

Authors:  Eran Mick; Alexandra Tsitsiklis; Natasha Spottiswoode; Saharai Caldera; Paula Hayakawa Serpa; Angela M Detweiler; Norma Neff; Angela Oliveira Pisco; Lucy M Li; Hanna Retallack; Kalani Ratnasiri; Kayla M Williamson; Victoria Soesanto; Eric A F Simões; Christiana Smith; Lisa Abuogi; Amy Kistler; Brandie D Wagner; Joseph L DeRisi; Lilliam Ambroggio; Peter M Mourani; Charles R Langelier
Journal:  Nat Commun       Date:  2022-07-08       Impact factor: 17.694

9.  Prediction of Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Quantitative Digital Polymerase Chain Reaction Normalized to International Units.

Authors:  Diego R Hijano; Zhengming Gu; Jessica Brazelton; Haiqing Zhu; Sri Suganda; Heather L Glasgow; Himani Darji; Li Tang; Thomas P Fabrizio; Kim J Allison; E Kaitlynn Allen; Aditya H Gaur; Joshua Wolf; Paul G Thomas; Richard J Webby; Randall T Hayden
Journal:  Open Forum Infect Dis       Date:  2022-09-21       Impact factor: 4.423

10.  Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Detection Testing in Symptomatic and Asymptomatic Children in the Clinical Setting.

Authors:  Arnaud G L'Huillier; Matthieu Lacour; Debora Sadiku; Mehdi A Gadiri; Loraine De Siebenthal; Manuel Schibler; Isabella Eckerle; Selina Pinösch; Laurent Kaiser; Alain Gervaix; Alban Glangetas; Annick Galetto-Lacour; Laurence Lacroix
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 11.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.